Arthneeti
Medi Assist Ser. Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹242 Cr +3.9% YoYSee revenue, profit and what management said. You are viewing Q4 FY25.
MA

Medi Assist Ser.

Q4 FY25Insurance

Medi Assist Healthcare Services Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management said on revenue, margins and capex.

Revenue
₹189Cr
+13.2% YoY
+1.6% QoQ
Net profit
₹22Cr
−15.4% YoY
−26.7% QoQ
Margin
22%
0 pp YoY
+1 pp QoQ
Price₹361
Market cap₹2.6K Cr
P/E26.4

The short version

Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing 29.4% vs industry 12.2%. Medi Assist expects continued growth driven by evolving from a pure TPA model to a health benefits administrator, focusing on unbundled, technology-driven services (Page 17).

From Medi Assist Ser.'s Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing 29.4% vs industry 12.2%.
  • Focus on evolving from a pure TPA to a health benefits administrator with unbundled SaaS and technology offerings to increase revenue streams.
  • Increasing adoption of add-on/top-up voluntary products in group insurance, improving revenue per life.
  • Growing technology contracts (~1.5%-2% of revenues) with SaaS models expected to scale up as insurers see value in unbundled services.
  • Continued investments in technology for fraud detection and cashless network to create value and enable higher revenue.

2 more points from Medi Assist Ser.'s call on revenue

Create a free account to keep reading this call

Profitability & Margins

Medi Assist expects continued growth driven by evolving from a pure TPA model to a health benefits…

Locked: what Medi Assist Ser. said on margins

Also locked on this page: fundraising

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

  • The company continues to invest annually about 5% to 7% of revenues in technology to build core differentiation and innovation (Page 6).
  • Investments focus on enabling unbundling of services, enabling new SaaS offerings and platform businesses that leverage existing capabilities (Page 10-11).
  • These technology investments have proven track records with payout in enhanced monetization, insurance company recognition, and potential for operating leverage (Page 11).
  • Acquisition strategy remains targeted and strategic, such as the recent Paramount TPA acquisition to build a pan-India platform and strengthen insurer relationships (Page 14).

2 more points from Medi Assist Ser.'s call on capex

Create a free account to keep reading this call

Top-ranked in Insurance

Ranked on what management guided this quarter

Guidance-ranked
1Niva Bupa Health
Rev 2Mar 3
2Max Financial
Rev 3Mar 2
3
Rev 3Mar 3
Sign up free to see 1 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Any developments regarding fundraising will be communicated to shareholders and the public as they occur.

Locked: what Medi Assist Ser. said on fundraising

Also locked on this page: margins

Free account, 30 seconds. No card needed.

Order Book & Pipeline

The following related points can be noted: - The company has recently received regulatory approval to acquire 100% equity in Paramount Health Services & Insurance TPA Private Limited, indicating strategic expansion. - Medi Assist continues to build partnerships and grow in the third-party administration (TPA) and health benefits administration market, with a focus on unbundling services and technology. - The company reports strong premium under management (over ₹20,000 crore) with growth in both group and retail segments.

2 more points from Medi Assist Ser.'s call on order book

Create a free account to keep reading this call

Medi Assist Ser. — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Medi Assist Ser. Q4 FY25 results — key figures

Medi Assist Ser. Q4 FY25 reported results vs Q4 FY24, ₹ crore
₹ CrQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue189167+13.2%186+1.6%
Operating profit (EBITDA)4137+10.8%40+2.5%
Operating margin22%22%0 pp21%+1 pp
Profit before tax3028+7.1%27+11.1%
Net profit (PAT)2226-15.4%30-26.7%
EPS (₹)3.053.58-14.8%4.19-27.2%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹242 Cr, net profit ₹22 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Medi Assist Healthcare Services's management said in earlier quarters

Earlier calls (4)

Others in Insurance this season

  • Max Financial (Q4 FY25)

    Individual adjusted first year premium grew 20% in FY '25, surpassing private sector growth of 15% and industry growth of 10%. Key concall takeaways from Max…

  • ICICI Lombard (Q4 FY25)

    Focus on profitable growth with a strong emphasis on driving Return on Equity (ROE) between 16% to 20% for sustainable value creation. Key concall takeaways…

  • Niva Bupa Health (Q4 FY25)

    The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25. Key concall takeaways from Niva Bupa Health Insurance Company…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Medi Assist Ser. and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Medi Assist Ser. Q4 FY25 results?

Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing 29.4% vs industry 12.2%. Medi Assist expects continued growth driven by evolving from a pure TPA model to a health benefits administrator, focusing on unbundled, technology-driven services (Page 17).

What is Medi Assist Ser. share price analysis?

Medi Assist Ser. currently shows a neutral. The stock trades at a P/E of 26.4 with a market cap of ₹2,605 Cr. Investors should review the full earnings analysis for detailed insights.

Is Medi Assist Ser. planning capital expenditure?

The company continues to invest annually about 5% to 7% of revenues in technology to build core differentiation and innovation (Page 6).

Keep Medi Assist Ser. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.